INTERFERON BETA DRUGS MARKET ANALYSIS INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2020–2027
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION Interferon Beta Drugs Market - Overview Global Interferon Beta Drugs Market, by Product Type (Interferon Beta-1A, Interferon Beta-1B, and Peginterferon Beta-1A), by Route of Administration (Intramuscular, Subcutaneous, and Intravenous), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), is estimated to be valued at US$ 3,795.3 million in 2020 and is expected to exhibit a CAGR of 3.5% during the forecast period (2020-2027), as highlighted in a new report published by Coherent Market Insights. Various research institutes, pharmaceutical and biotechnology companies are engaged in conducting clinical studies on interferon beta drugs to evaluate their effectiveness against various health conditions such as multiple sclerosis, malignant solid tumor, COVID-19, chronic obstructive pulmonary disease (COPD). For instance, in October 2018, Biogen initiated phase 2 clinical trial to evaluate safety, tolerability, and descriptive efficacy of BIIB017 (peginterferon beta-1a) in pediatric participants with relapsing-remitting multiple sclerosis (RRMS). Moreover, on August 4, 2020, National Institute of Allergy and Infectious Diseases (NIAID) initiated phase 3 clinical study (ACTT-3) to evaluate the effectiveness of a combination of interferon beta-1a and remdesivir compared to remdesivir alone for the treatment of COVID-19. Thus, the increasing number of clinical studies is expected to provide an opportunity for the market players to introduced novel interferon beta drugs targeting various disease conditions.
Browse Research Reports: https://www.coherentmarketinsights.com/marketinsight/interferon-beta-drugs-market-4250 Š Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION According the World Health Organization, in December 2019, the manifestation of coronavirus disease (COVID-19) resulted in more than 36.6 million infected individuals worldwide as of October 2020. Furthermore, several research institutes and biotechnology companies are engaged in clinical trials of interferon beta drugs as a potential treatment for COVID-19. For instance, in March 2020, the World Health Organization (WHO) announced a large scale global trial called SOLIDARITY, to find out whether any drug can treat the coronavirus infection. Under this mega trial, the WHO is focusing on the four most promising therapies including remdesivir (an experimental antiviral compound) chloroquine, and hydroxychloroquine (the malaria medications), a combination of two HIV drugs, lopinavir and ritonavir, and that same combination plus interferon-beta, an immune system messenger that can help cripple viruses. Browse 28 Market Data Tables and 30 Figures spread through 169 Pages and in-depth TOC on “Global Interferon Beta Drugs Market, by Product Type (Interferon Beta-1A, Interferon Beta1B, and Peginterferon Beta-1A), by Route of Administration (Intramuscular, Subcutaneous, and Intravenous), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa).
The spread of the novel coronavirus has hampered growth of the healthcare industry and the virus spread rapidly across the globe causing a concerning number of fatalities. Request a Sample copy of this reports : https://www.coherentmarketinsights.com/insight/request-sample/4250 Š Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION The major factors driving growth of the global interferon beta drugs market include an increasing number of research and development activities, approval and launch of novel drug candidates and the rising prevalence of the multiple sclerosis in children. For instance, in 2014, Plegridy (peginterferon beta-1a), a disease modifying therapy, was approved by the U.S. Food and Drug Administration for the long-term treatment of relapsing forms of multiple sclerosis. According to Multiple Sclerosis Society, around 5-10% of people with MS experienced their first symptoms before the age of 16. Key Takeaways of the Global Interferon Beta Drugs Market: The global interferon beta drugs market is expected to exhibit a CAGR of 3.5% during the forecast period due to an increasing number of research and development activities by biotechnology companies. On the basis of product type, the interferon beta-1a segment holds a dominant position in the global interferon beta drugs market due to availability of a large number of drugs in the interferon beta-1a category. On the basis of route of administration, intramuscular segment holds a dominant position in the global interferon beta drugs market. Key players operating in the global interferon beta drugs market are Biogen Idec., Merck KGaA, Novartis Pharmaceuticals Corporation, and Bayer.
Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/4250 Š Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele.
SERVICES INDUSTRY ANALYSIS
CUSTOMIZED RESEARCH
SYNDICATED RESEARCH
MARKET INTELLIGENCE SERVICES
CONSULT STUDIES
COUNTRY SPECIFIC STUDIES
Š Coherent market Insights. All Rights Reserved
ABOUT CMI SECTOR COVERAGE
BIOTECHNOLOGY
CLINICAL DIAGNOSTIC
HEALTHCARE IT
MEDICAL DEVICES
MEDICAL IMAGING
PHARMACEUTICAL
OUR CLIENTS
Global Leading Equipment and System Manufacturers Marketing Consultancies and the Advertising Industry Component Providers and System Integrators
Private and Government organization
Distributors, Retailors and Value Added Resellers
Outsourcing Companies
Healthcare IT Solutions Developers
Universities and Business Schools.
© Coherent market Insights. All Rights Reserved
KEY STATS
RESEARCH SOLUTIONS
100+
FEASIBILITY STUDIES
Insights Published Per Year
GLOBAL REPORTS
150+
Consulting Projects Till Date
COUNTRY ANALYSIS CONSULT PROJECTS
125+
Clients Worldwide Per Year
110+
SURVEY RESEARCH
EXCEL FORECAST DATABASE
CUSTOMIZED SOLUTIONS
COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS
Analysts and Contract Consultants
Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved
THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702
Š Coherent market Insights. All Rights Reserved